000 01320cam a2200289 4500500
005 20250112040114.0
041 _afre
042 _adc
100 1 0 _aLamarque, Catherine
_eauthor
700 1 0 _a Lamarque, Dominique
_eauthor
245 0 0 _aAn update on the prevention of bleeding ulcers in 2023
260 _c2023.
500 _a49
520 _aPeptic ulcer disease is a known complication in patients in intensive care units or on anticoagulants who are being given non-steroidal anti-inflammatory drugs. Screening and treatment for Helicobacter pylori should be offered to patients starting NSAID therapy. Proton pump inhibitors should be given to patients at high risk of developing a bleeding ulcer and dying from this complication.
690 _arisk-benefit
690 _anon-steroidal anti-inflammatory drugs
690 _aproton pump inhibitor
690 _apeptic ulcer
690 _aHelicobacter pylori
690 _arisk-benefit
690 _anon-steroidal anti-inflammatory drugs
690 _apulcer
690 _aproton pump inhibitor
690 _aHelicobacter pylori
786 0 _nHépato-Gastro & Oncologie Digestive | 30 | 3 | 2023-03-02 | p. 335-342 | 2115-3310
856 4 1 _uhttps://shs.cairn.info/journal-hepato-gastro-et-oncologie-digestive-2023-3-page-335?lang=en
999 _c175211
_d175211